Opinion: Incentives and information drive health care innovation: lessons from Medicare Advantage
Health care in America often feels like it moves at a glacial pace, if that…
Author: STAT
‘Still waiting for my turn’: Primary care doctors are being left behind in the vaccine rollout
In March, Marc Price set up a tent outside his primary care practice in Malta,…
Britain takes a gamble with Covid-19 vaccines, upping the stakes for the rest of us
In an extraordinary time, British health authorities are taking extraordinary measures to beat back Covid-19….
STAT+: The biotech 2021 preview, from M&A to gene therapy and more
Hello, Biotech 2021. In the interest of humility, we’ll note that last year’s preview story…
Five key milestones in the Covid-19 pandemic that we’re anticipating in 2021
On the first day of fall, STAT published its best guesses of 30 moments to…
Pfizer and BioNTech speed up timeline for offering Covid-19 to placebo volunteers
Pfizer and its partner BioNTech plan to start offering their Covid-19 vaccine to clinical trial…
Opinion: Who’s choosing Americans’ medications — doctors or insurers? The bane of prior authorization
New Year’s Day, the day of new beginnings, is a day health care providers like…
STAT+: Indian regulators are pushed to release Covid-19 vaccine trial protocol
As Indian regulators consider emergency approval of a Covid-19 vaccine from the Serum Institute of…
Opinion: As a doctor in the Covid-19 era, I’ve learned that judging patients’ decisions comes easier than it should
Mrs. Gomes, my umpteenth patient of the day, is an older woman — only slightly…
.jpg)
With limited surveillance of Covid-19 variant, it’s déjà vu all over again
As health officials in the United States announced a second and possibly a third person…
We wish we’d written that: STAT staffers share their favorite stories of 2020
It has been a long, tough year unlike any other. As the new coronavirus tore…
STAT+: 3 pharma trends to watch in 2021
To say this past year has been like no other is an understatement. But for…
Opinion: Stopping the syndemic: Covid-19 plus other debilitating and deadly diseases
With Covid-19 vaccines beginning to be distributed in the United States and other countries, and…
Opinion: 5 most widely read First Opinion articles of 2020
In a year of crisis and tragedy, 2020 lent itself to an abundance of opinions…
STAT+: 3 freshman lawmakers for health wonks to watch
WASHINGTON — Members of Congress have a habit of contorting their resumes to find a…
As a nurse, she knew the daily traumas of Covid-19. Then her father landed in her ICU
Even on his second trip to the emergency room, Tom McNamara wasn’t especially afraid of…
Public health experts grow frustrated with pace of Covid-19 vaccine rollout
WASHINGTON — Some public health experts are expressing mounting frustration with the pace of the…
Opinion: David Dinkins, former NYC mayor, a teacher for our times
In the decades before Covid-19, two frightening infectious disease epidemics — HIV/AIDS and tuberculosis —…
Opinion: We stress tested banks in 2009. We need to do the same thing now for U.S. hospital systems
Following the market turmoil after the failure of Lehman Brothers in the fall of 2008,…
Explanations for ‘long Covid’ remain elusive. For now, believing patients and treating symptoms is the best doctors can do
Nearly a year into the coronavirus pandemic, the perplexing problems of Covid-19 long-haulers seem no…
3 global health issues to watch in 2021
In December 2018, when I set out to write about the global health issues the…
STAT+: 3 biotech trends to watch
For biotech companies, 2020 could have been a lot worse than it was, all things…
Opinion: We need long-term solutions for older Americans’ long-term care
“Mom is getting older,” my brother said to me as we chatted on the phone….
STAT+: 3 key questions for the health tech industry in 2021
Fueled by a seemingly endless influx of cash, technology has influenced the practice of medicine…
STAT+: 3 Biden staffers to watch in 2021
WASHINGTON — President-elect Biden is set to take office Jan. 20, and he’s made repeatedly…
The curse of the incidental illness: Seen as side effects to Covid vaccinations, ailments may have little to do with them
As Covid-19 vaccines go into broad use, some rare side effects of vaccination will almost…
Opinion: STAT+: ‘There are a lot of potential Modernas’: The ‘Massachusetts Miracle’ is alive and well
With the Moderna vaccine, Massachusetts is having a moment. Ours is a story not about…
.jpg)
Opinion: Routine testing is essential to combat Covid-19 surges
As the latest surge in Covid-19 cases pushes cases and deaths higher — nearly 18…
Opinion: My first dose of a Covid-19 vaccine got me thinking about time
I received my first dose of the Pfizer-BioNTech coronavirus vaccine on a Wednesday, as soon…
Charting the Covid-19 pandemic in 2020, through STAT headlines
At this point, the Covid-19 pandemic — and its impact on the world — needs…
STAT+: Federal judge places restraining order on Trump’s latest drug pricing rule
WASHINGTON — A federal judge on Wednesday issued a temporary restraining order preventing one of…
STAT+: Pharmalittle: Feds sue Walmart over opioid prescriptions; U.S. buys more Pfizer vaccine doses
Good morning, everyone. Damian Garde here, filling in for Ed Silverman one last time as…
Opinion: Let’s put the straw man of pandemic denial out of his misery
Listen to the chorus and you’d come to think that our biggest problem in responding…
Opinion: Covid-19 vaccines are safe. But let’s be clear about what ‘safe’ means
Unprecedented collaborative efforts in vaccine development have culminated in multiple vaccines being tested in advanced…
STAT+: How 2020 became the year of the biotech SPAC
Over the past year, the humble blank-check IPO has risen from a disreputable relic of…
‘Every day is an emergency’: The pandemic is worsening psychiatric bed shortages nationwide
The Covid-19 pandemic has dramatically cut the availability of inpatient psychiatric beds, with facilities across…
‘There’s no back to normal’: For people with terminal illnesses, time lost to Covid-19 can’t be made up
After Aaron Hoover found out he had glioblastoma in 2019, a new imperative imbued each…
STAT+: STAT+ Conversations: A conversation with Nobel laureate Charles Rice
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET. …
STAT+: Pharmalittle: EU clears Pfizer’s Covid-19 vaccine; Americans are increasingly willing to get the shot
Good morning, everyone. Damian Garde here, filling in for Ed Silverman once more in the…
Watch: What to expect when you’re injected: Vaccine side effects explained
Vaccinations for Covid-19 are now underway in the U.S. Two vaccines – one from Pfizer…
Opinion: Let the ultra-rich and influential skip the line for Covid-19 vaccines? Hear me out
It’s one thing to talk about vaccinating the majority of people living in the United…
STAT+: The most impressive biotech VCs of 2020
Behind almost every biotech IPO, every merger, and every buyout are a set of venture…
STAT+: Health tech’s newest unicorn is running toward Medicaid patients long marginalized in medicine
It has become a business imperative in American medicine to marginalize patients on Medicaid. Their…
3 lessons from Stanford’s Covid-19 vaccine algorithm debacle
Stanford found itself in hot water last week after deploying a faulty Covid-19 vaccine distribution…
The looming questions scientists need to answer about the new variant of the coronavirus
A variant of the coronavirus that emerged in the United Kingdom has forced London to…
Opinion: Looking back and looking ahead: Vioxx, drug safety, and the legacy of Sen. Michael Enzi
The prescription painkiller originally known as Vioxx may be making a comeback after its maker,…
STAT+: Pharmalittle: Moderna’s Covid-19 vaccine rolls out across the U.S.; FDA rejects Novartis cholesterol drug
Good morning, one and all. Damian Garde here, filling in for Ed Silverman on this…
STAT+: Uniqure’s hemophilia B gene therapy program on hold due to cancer diagnosis in treated patient
UniQure, the Dutch gene therapy company, said Monday that it had temporarily halted the clinical…
STAT+: Agios sells cancer business to French drug maker for up to $2 billion, will now focus on inherited diseases
Agios Pharmaceuticals said Monday that it is selling its cancer business to the French drug…
STAT’s most memorable photos of 2020
This year was one that no one could have imagined — 2020 has been marked…